Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

YAP1 inhibitor

DRUG CLASS:

YAP1 inhibitor

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

YAP1 overexpression + WWTR1 overexpression

Hepatocellular Cancer

sorafenib + CA3

Sensitive: D – Preclinical

sorafenib + CA3

sorafenib + CA3

Sensitive: D – Preclinical

sorafenib + CA3